Skip to content

FBIO - Fortress Biotech, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchF

Fortress Biotech Inc

FBIO · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

F

FBIOFortress Biotech Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $4.53
52-wk low: $2.18
Prev close: $3.47
Mkt cap: $95.0M
P/E: 1.1x
Fwd P/E: 1.2x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$2.2M

TS
Two Sigma
Q2 2026 13F
$654K
position
JS
Jim Simons
Q2 2026 13F

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

Fairly priced and profitable.

Net margin: 163.3%
P/E: 1.05
Forward P/E: 1.21
Market cap: $95M

Valuation

P/S1.39
P/B0.59

Quality

Operating margin-53.5%

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: FBIO
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $95.05M
Beta: 1.21

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Beta

1.21

P/S

1.4x

P/B

0.6x

Profit margin

+163.3%

Op margin

-53.5%

ROE

+116.0%

$264K

position

CI

Citadel

Ken Griffin · Q2 2026 13F

$236K

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for FBIO

No recent insider trade
No recent Congress trade
No recent market-voice mention

The latest quarter is still settling.

A verdict appears once the reported figure is final

Next report

What the street expects next

EPS expected

-$0.15

-$0.15 to -$0.15

Revenue expected

$22.3M

1 analysts

Last 30 days

1up0down

Analysts raising estimates

Estimate drift

+0.01

Change in 30 days

ROE116.0%

ROA-7.6%

Growth

Beta1.21